Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Study reveals possible new treatment targets for diffuse intrinsic pontine gliomas

Study led by St. Jude Children's Research Hospital scientists points to possible new treatment targets for diffuse intrinsic pontine gliomas; may tip the scales in the current debate about tumor biopsies.

21 Sep 2011

MRI screenings for breast cancer benefit high-risk, underserved women

Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general risk mammography screenings.

21 Sep 2011

MDA, IMRIS collaborate to advance development of MR guided surgical robot

IMRIS Inc. and MacDonald, Dettwiler and Associates Ltd. today announced an agreement for the final phases of collaborative development of IMRIS's MR guided surgical robot, building on the development work the two companies have completed to date.

20 Sep 2011

Hologic to showcase automated systems for cervical cancer screening at IPV, Berlin

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on two new, ready-to-market automated options for cervical cancer screening at the International Papillomavirus Conference & Clinical Workshop (IPV) September 17th through 22nd in Berlin, Germany.

From Hologic, Inc. 17 Sep 2011

New GE healthymagination initiative aims to improve cancer innovation and care

GE and leading healthcare and financial partners today launched a new healthymagination initiative aimed at accelerating cancer innovation and improving care for 10 million cancer patients around the world by 2020.

16 Sep 2011

Curcumin suppresses cell signaling pathway that drives growth of head and neck cancer

Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center.

14 Sep 2011

Aggressive medical management better than stenting for prevention of recurrent stroke

Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.

8 Sep 2011

Studies examine overuse of scans in determining status of prostate cancer

During Prostate Cancer Awareness Month, researchers will publish the findings of two studies examining the use, or overuse, of scans in determining the status or level of a patient's prostate cancer after diagnosis. "Typically, patients with an elevated PSA level undergo a prostate biopsy to confirm the presence of cancer.

8 Sep 2011

New guidelines for treatment of melanoma

Based on an extensive review of scientific literature and the recommendations of recognized melanoma experts, the American Academy of Dermatology (Academy) has released updated evidence-based guidelines for the treatment of melanoma, the deadliest form of skin cancer.

8 Sep 2011

New implantable micro oxygen generator improves effectiveness of anticancer tharapy

Researchers have created and tested miniature devices that are implanted in tumors to generate oxygen, boosting the killing power of radiation and chemotherapy.

2 Sep 2011

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

Bristol-Myers Squibb Company today announced that new data on NULOJIX (belatacept) will be presented at the European Society for Organ Transplantation (ESOT) Congress on September 4 -7, 2011 in Glasgow, Scotland, United Kingdom.

2 Sep 2011

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.

26 Aug 2011

MDxHealth first half 2011 commercial revenues increase 19%

MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.

25 Aug 2011

Stem cells of oral mucosa stay young, says Tel Aviv University researcher

While highly potent embryonic stem cells are often the subject of ethical and safety controversy, adult-derived stem cells have other problems. As we age, our stem cells are less pliant and less able to transform into the stem cells that science needs to find breakthrough treatments for disease.

23 Aug 2011

St. Joseph's Women's Hospital inaugurates new 64-suite neonatal intensive care unit

Most expectant mothers enjoy optimistic dreams of delivering a healthy baby and soon leaving the hospital with their new bundle of joy.

20 Aug 2011

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.

18 Aug 2011

Conference to expand awareness about benefits of human tissue research

When you have blood taken for a test or have tissue removed for a biopsy, it may be used for medical research. While there are clear benefits to such research, medical and health care professionals need to be aware of cultural and confidentiality concerns on the part of patients.

18 Aug 2011

Optical coherence tomography can distinguish between high and low risk pancreatic cysts

A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant.

18 Aug 2011

Health Canada grants medical device license to Gen-Probe's PROGENSA PCA3 assay

Gen-Probe announced today that Health Canada has granted the Company a medical device license for the PROGENSA(R) PCA3 assay, a new molecular urine test that helps determine the need for repeat biopsies in men suspected of having prostate cancer.

17 Aug 2011

Novel assay can accurately detect prostate cancer than traditional screening

new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer.

16 Aug 2011

Biopsy News and Research

Further Reading

Study reveals possible new treatment targets for diffuse intrinsic pontine gliomas

MRI screenings for breast cancer benefit high-risk, underserved women

MDA, IMRIS collaborate to advance development of MR guided surgical robot

Hologic to showcase automated systems for cervical cancer screening at IPV, Berlin

New GE healthymagination initiative aims to improve cancer innovation and care

Curcumin suppresses cell signaling pathway that drives growth of head and neck cancer

Aggressive medical management better than stenting for prevention of recurrent stroke

Studies examine overuse of scans in determining status of prostate cancer

New guidelines for treatment of melanoma

New implantable micro oxygen generator improves effectiveness of anticancer tharapy

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

MDxHealth first half 2011 commercial revenues increase 19%

Stem cells of oral mucosa stay young, says Tel Aviv University researcher

St. Joseph's Women's Hospital inaugurates new 64-suite neonatal intensive care unit

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Conference to expand awareness about benefits of human tissue research

Optical coherence tomography can distinguish between high and low risk pancreatic cysts

Health Canada grants medical device license to Gen-Probe's PROGENSA PCA3 assay

Novel assay can accurately detect prostate cancer than traditional screening

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News